ANGO vs HUBS · rev $292.5M vs P/E 96, rev $2.63B
AngioDynamics Inc (ANGO) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported HUBS revenue for 2024-12-31 was $2.63B. Net income was $4.6M. Revenue was up 21.1% from 2023-12-31 to 2024-12-31. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
ANGO currently screens at market cap $378.5M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the ANGO and HUBS stock pages for the full models.
Not investment advice.